HomeCompareCYDVF vs JNJ

CYDVF vs JNJ: Dividend Comparison 2026

CYDVF yields 736.02% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CYDVF wins by $1378165.36M in total portfolio value
10 years
CYDVF
CYDVF
● Live price
736.02%
Share price
$0.27
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1378165.39M
Annual income
$1,087,509,869,983.15
Full CYDVF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — CYDVF vs JNJ

📍 CYDVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYDVFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYDVF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CYDVF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYDVF
Annual income on $10K today (after 15% tax)
$62,562.10/yr
After 10yr DRIP, annual income (after tax)
$924,383,389,485.68/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, CYDVF beats the other by $924,383,385,499.69/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYDVF + JNJ for your $10,000?

CYDVF: 50%JNJ: 50%
100% JNJ50/50100% CYDVF
Portfolio after 10yr
$689082.71M
Annual income
$543,754,937,336.28/yr
Blended yield
78.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CYDVF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
193.3
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYDVF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYDVFJNJ
Forward yield736.02%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$1378165.39M$30.3K
Annual income after 10y$1,087,509,869,983.15$4,689.40
Total dividends collected$1354845.92M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: CYDVF vs JNJ ($10,000, DRIP)

YearCYDVF PortfolioCYDVF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$84,302$73,602.47$10,592$272.30+$73.7KCYDVF
2$670,098$579,894.44$11,289$357.73+$658.8KCYDVF
3$5,024,881$4,307,876.34$12,123$472.89+$5.01MCYDVF
4$35,566,885$30,190,261.90$13,141$629.86+$35.55MCYDVF
5$237,768,091$199,711,523.85$14,408$846.81+$237.75MCYDVF
6$1,502,160,450$1,247,748,592.92$16,021$1,151.60+$1502.14MCYDVF
7$8,974,572,821$7,367,261,139.73$18,122$1,588.22+$8974.55MCYDVF
8$50,738,574,083$41,135,781,164.49$20,930$2,228.20+$50738.55MCYDVF
9$271,640,674,071$217,350,399,801.56$24,792$3,191.91+$271640.65MCYDVF
10$1,378,165,391,239$1,087,509,869,983.15$30,274$4,689.40+$1378165.36MCYDVF

CYDVF vs JNJ: Complete Analysis 2026

CYDVFStock

Century Lithium Corp. engages in the acquisition, exploration, evaluation, and development of resource properties in the United States. It primarily explores for lithium. The company holds 100% interests in Clayton Valley project located in southwest Nevada; Dean lithium property in Clayton Valley, Nevada; Glory lithium property in Clayton Valley; and Gunman Project, White Pine Claims, Nevada, as well as interest in Enertopia Project. Century Lithium Corp. was formerly known as Cypress Development Corp. and changed its name to Century Lithium Corp. in January 2023. The company was incorporated in 1991 and is headquartered in Vancouver, Canada.

Full CYDVF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CYDVF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYDVF vs SCHDCYDVF vs JEPICYDVF vs OCYDVF vs KOCYDVF vs MAINCYDVF vs ABBVCYDVF vs MRKCYDVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.